title: Reversal of fluoxetine-induced sexual dysfunction by switching to escitalopram.
abstract: Sexual dysfunction is a common complaint among patients taking selective serotonin reuptake-inhibiting (SSRI) antidepressants. Many options in managing this side effect have been described but none clearly is a first choice among clinicians. This paper describes the first published case of a patient having successful reversal of SSRI-induced sexual dysfunction by switching from an SSRI to escitalopram, the newest antidepressant and SSRI approved for use in the United States. Clinical implication is discussed.
authors.forename: Adam Keller
authors.initials: AK
authors.lastname: Ashton
mesh_terms: D000328:Adult; D018687:Antidepressive Agents, Second-Generation / Q000008:administration & dosage / Q000009:adverse effects; D015283:Citalopram / Q000008:administration & dosage*; D005473:Fluoxetine / Q000008:administration & dosage / Q000009:adverse effects*; D006801:Humans; D008297:Male; D017367:Selective Serotonin Reuptake Inhibitors / Q000008:administration & dosage* / Q000009:adverse effects*; D020018:Sexual Dysfunctions, Psychological / Q000139:chemically induced* / Q000188:drug therapy* / Q000523:psychology; D013997:Time Factors; D016896:Treatment Outcome; D014481:United States
chemical_list: D018687:Antidepressive Agents, Second-Generation; D015283:Citalopram; D005473:Fluoxetine; D017367:Selective Serotonin Reuptake Inhibitors